Bach P, Robinson S, Sutherland C, Brar R Innovative strategies to support physical distancing among individuals with active addiction Lancet Psychiatry PubMed

Brar R, Fairbairn N, Colizza K, Ryan A, Nolan S Hospital initiated injectable opioid agonist therapy for the treatment of severe opioid use disorder: a case series J Addict Med PubMed

Brar R, Grant C, DeBeck K, Milloy MJ, Fairbairn N, Wood E, Kerr T, Hayashi K Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada Am J Drug Alcohol Abuse PubMed

Brar R, Fairbairn N, Sutherland C, Nolan S Use of a novel prescribing approach for the treatment of opioid use disorder: buprenorphine/naloxone micro-dosing - a case series Drug Alcohol Rev PubMed

Socías ME, Wood E, Dong H, Brar R, Bach P, Murphy SM, Fairbairn N Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): protocol for a non-inferiority randomized clinical trial Contemp Clin Trials PubMed

Caulfield MDG, Brar R, Sutherland C, Nolan S Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach BMJ Case Rep PubMed